Studies in patients with NDM due to activating mutations in KCNJ11 found that these patients were able to effectively switch from insulin to high-dose SU, with resulting tight glycemic control while avoiding hypoglycemia. This evidence concerns the gene KCNJ11 and neonatal diabetes mellitus.